File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Topical imiquimod before intradermal trivalent influenza vaccine for protection against heterologous non-vaccine and antigenically drifted viruses: a single-centre, double-blind, randomised, controlled phase 2b/3 trial

TitleTopical imiquimod before intradermal trivalent influenza vaccine for protection against heterologous non-vaccine and antigenically drifted viruses: a single-centre, double-blind, randomised, controlled phase 2b/3 trial
Authors
Hung, FNIZhang, JTo, KKWChan, JFWLi, TWWong, TLZhang, RChan, TCIChan, BCWai, HHChan, LWFong, HPHui, RKKong, KLLeung, ACNgan, AHTsang, LWYeung, APYiu, GCYung, WLau, JYChen, HChan, KHYuen, KY
Issue Date2016
PublisherThe Lancet Publishing Group. The Journal's web site is located at http://www.elsevier.com/locate/j.lancetid
Citation
The Lancet Infectious Diseases, 2016, v. 16 n. 2, p. 209-218 How to Cite?
DOI: http://dx.doi.org/10.1016/S1473-3099(15)00354-0
Persistent Identifierhttp://hdl.handle.net/10722/229631
ISSN
1473-3099
2021 Impact Factor: 71.421
2020 SCImago Journal Rankings: 7.475
ISI Accession Number ID
WOS:000368567000033

 

DC FieldValueLanguage
dc.contributor.authorHung, FNI-
dc.contributor.authorZhang, J-
dc.contributor.authorTo, KKW-
dc.contributor.authorChan, JFW-
dc.contributor.authorLi, TW-
dc.contributor.authorWong, TL-
dc.contributor.authorZhang, R-
dc.contributor.authorChan, TCI-
dc.contributor.authorChan, BC-
dc.contributor.authorWai, HH-
dc.contributor.authorChan, LW-
dc.contributor.authorFong, HP-
dc.contributor.authorHui, RK-
dc.contributor.authorKong, KL-
dc.contributor.authorLeung, AC-
dc.contributor.authorNgan, AH-
dc.contributor.authorTsang, LW-
dc.contributor.authorYeung, AP-
dc.contributor.authorYiu, GC-
dc.contributor.authorYung, W-
dc.contributor.authorLau, JY-
dc.contributor.authorChen, H-
dc.contributor.authorChan, KH-
dc.contributor.authorYuen, KY-
dc.date.accessioned2016-08-23T14:12:18Z-
dc.date.available2016-08-23T14:12:18Z-
dc.date.issued2016-
dc.identifier.citationThe Lancet Infectious Diseases, 2016, v. 16 n. 2, p. 209-218-
dc.identifier.issn1473-3099-
dc.identifier.urihttp://hdl.handle.net/10722/229631-
dc.languageeng-
dc.publisherThe Lancet Publishing Group. The Journal's web site is located at http://www.elsevier.com/locate/j.lancetid-
dc.relation.ispartofThe Lancet Infectious Diseases-
dc.rightsPosting accepted manuscript (postprint): © <year>. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/-
dc.titleTopical imiquimod before intradermal trivalent influenza vaccine for protection against heterologous non-vaccine and antigenically drifted viruses: a single-centre, double-blind, randomised, controlled phase 2b/3 trial-
dc.typeArticle-
dc.identifier.emailHung, FNI: ivanhung@hkucc.hku.hk-
dc.identifier.emailZhang, J: zhangajx@hkucc.hku.hk-
dc.identifier.emailTo, KKW: kelvinto@hkucc.hku.hk-
dc.identifier.emailChan, JFW: jfwchan@hku.hk-
dc.identifier.emailLi, TW: twli2000@hku.hk-
dc.identifier.emailWong, TL: tlwong26@HKUCC-COM.hku.hk-
dc.identifier.emailChan, TCI: tuenchin@hku.hk-
dc.identifier.emailChen, H: hlchen@hku.hk-
dc.identifier.emailChan, KH: chankh2@hkucc.hku.hk-
dc.identifier.emailYuen, KY: kyyuen@hkucc.hku.hk-
dc.identifier.authorityHung, FNI=rp00508-
dc.identifier.authorityZhang, J=rp00413-
dc.identifier.authorityTo, KKW=rp01384-
dc.identifier.authorityChan, JFW=rp01736-
dc.identifier.authorityChen, H=rp00383-
dc.identifier.authorityChan, KH=rp01921-
dc.identifier.authorityYuen, KY=rp00366-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1016/S1473-3099(15)00354-0-
dc.identifier.pmid26559482-
dc.identifier.scopuseid_2-s2.0-84957715312-
dc.identifier.hkuros260028-
dc.identifier.volume16-
dc.identifier.issue2-
dc.identifier.spage209-
dc.identifier.epage218-
dc.identifier.isiWOS:000368567000033-
dc.publisher.placeUnited Kingdom-
dc.identifier.issnl1473-3099-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats